Skip to main content
Top
Published in: BMC Health Services Research 1/2021

01-12-2021 | Huntington's Disease | Research article

Health services utilization of Chinese patients with Huntington’s disease: a cross-sectional study

Authors: Huiyi Ke, Xi Cao, Yanyan Song, Li Cao

Published in: BMC Health Services Research | Issue 1/2021

Login to get access

Abstract

Background

Huntington’s disease (HD) is a hereditary disease which could have a large impact on patients’ quality of life. As the neurodegenerative disorders progress, HD patients are expected to regularly take follow-up medical visits for proper treatment. This study aimed to analyze the general situation of health services utilization of Chinese HD patients and factors associated with their adherence to follow-up medical visits.

Methods

We collected data from a questionnaire-based investigation conducted by the Chinese Huntington’s Disease Association. Data from 232 respondents were included to investigate whether they adhered to regular follow-up medical visits and the influencing factors. Based on Andersen’s behavioral model, the independent variables were categorized into predisposing, enabling and need factors. The variables were analyzed by chi-square test and stepwise logistic regression analysis.

Results

Thirty-one point nine percent of the respondents had regular follow-up medical visits over the past year. Univariate analysis showed that there were significant differences with 6 factors (P < 0.05), among which, according to logistic regression, 2 enabling factors (reimbursement of health insurance, need for accompanying family members to follow-up visits) and 3 need factors (perceived stage of disease, perceived effectiveness of drugs, self-care ability) were independent influencing factors of follow-up medical behaviors of Chinese HD patients. The predisposing factors investigated here did not play a part in determining patients’ adherence to follow-up visits.

Conclusions

Poor adherence to medical visits among Chinese HD patients is derived from multiple factors, including reimbursement of health insurance, perceived stage of disease and effectiveness of drugs, need for accompanying family members and self-care ability. To promote HD patients’ health services utilization, the improvement of the health insurance system, the enhancement of social support and the development of therapeutic approaches still have a long way to go.
Appendix
Available only for authorised users
Literature
2.
go back to reference Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.CrossRefPubMed Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.CrossRefPubMed
3.
go back to reference Chen YY, Lai CH. Nationwide population-based epidemiologic study of Huntington’s Disease in Taiwan. Neuroepidemiology. 2010;35(4):250–4.CrossRefPubMed Chen YY, Lai CH. Nationwide population-based epidemiologic study of Huntington’s Disease in Taiwan. Neuroepidemiology. 2010;35(4):250–4.CrossRefPubMed
4.
go back to reference Li HL, Li XY, Dong Y, Zhang YB, Cheng HR, Gan SR, et al. Clinical and Genetic Profiles in Chinese Patients with Huntington’s Disease: A Ten-year Multicenter Study in China. Aging Dis. 2019;10(5):1003–11.CrossRefPubMedPubMedCentral Li HL, Li XY, Dong Y, Zhang YB, Cheng HR, Gan SR, et al. Clinical and Genetic Profiles in Chinese Patients with Huntington’s Disease: A Ten-year Multicenter Study in China. Aging Dis. 2019;10(5):1003–11.CrossRefPubMedPubMedCentral
5.
go back to reference Bartlett DM, Govus A, Rankin T, Lampit A, Feindel K, Poudel G, et al. The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington’s disease. J Neurol Sci. 2020;416:117022.CrossRefPubMed Bartlett DM, Govus A, Rankin T, Lampit A, Feindel K, Poudel G, et al. The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington’s disease. J Neurol Sci. 2020;416:117022.CrossRefPubMed
6.
go back to reference Jones C, Busse M, Quinn L, Dawes H, Drew C, Kelson M, et al. The societal cost of Huntington’s disease: are we underestimating the burden? Eur J Neurol. 2016;23(10):1588–90.CrossRefPubMedPubMedCentral Jones C, Busse M, Quinn L, Dawes H, Drew C, Kelson M, et al. The societal cost of Huntington’s disease: are we underestimating the burden? Eur J Neurol. 2016;23(10):1588–90.CrossRefPubMedPubMedCentral
7.
go back to reference Silva-Paredes G, Urbanos-Garrido RM, Inca-Martinez M, Rabinowitz D, Cornejo-Olivas MR. Economic burden of Huntington’s disease in Peru. BMC Health Serv Res. 2019;19(1):1017.CrossRefPubMedPubMedCentral Silva-Paredes G, Urbanos-Garrido RM, Inca-Martinez M, Rabinowitz D, Cornejo-Olivas MR. Economic burden of Huntington’s disease in Peru. BMC Health Serv Res. 2019;19(1):1017.CrossRefPubMedPubMedCentral
8.
go back to reference Divino V, Dekoven M, Warner JH, Giuliano J, Anderson KE, Langbehn D, et al. The direct medical costs of Huntington’s disease by stage. A retrospective commercial and Medicaid claims data analysis. J Med Econ. 2013;16(8):1043–50.CrossRefPubMed Divino V, Dekoven M, Warner JH, Giuliano J, Anderson KE, Langbehn D, et al. The direct medical costs of Huntington’s disease by stage. A retrospective commercial and Medicaid claims data analysis. J Med Econ. 2013;16(8):1043–50.CrossRefPubMed
9.
go back to reference Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.CrossRefPubMed Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.CrossRefPubMed
10.
go back to reference Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from 1998–2011. Psychosoc Med. 2012;9:Doc11.PubMedPubMedCentral Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from 1998–2011. Psychosoc Med. 2012;9:Doc11.PubMedPubMedCentral
11.
go back to reference Busse M, Al-Madfai DH, Kenkre J, Landwehrmeyer GB, Bentivoglio A, Rosser A. Utilisation of Healthcare and Associated Services in Huntington’s disease: a data mining study. PLoS Curr. 2011;3:Rrn1206.CrossRefPubMedPubMedCentral Busse M, Al-Madfai DH, Kenkre J, Landwehrmeyer GB, Bentivoglio A, Rosser A. Utilisation of Healthcare and Associated Services in Huntington’s disease: a data mining study. PLoS Curr. 2011;3:Rrn1206.CrossRefPubMedPubMedCentral
12.
go back to reference Ohlmeier C, Saum KU, Galetzka W, Beier D, Gothe H. Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data. BMC Neurol. 2019;19(1):318.CrossRefPubMedPubMedCentral Ohlmeier C, Saum KU, Galetzka W, Beier D, Gothe H. Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data. BMC Neurol. 2019;19(1):318.CrossRefPubMedPubMedCentral
13.
go back to reference van Walsem MR, Howe EI, Ruud GA, Frich JC, Andelic N. Health-related quality of life and unmet healthcare needs in Huntington’s disease. Health Qual Life Outcomes. 2017;15(1):6.CrossRefPubMedPubMedCentral van Walsem MR, Howe EI, Ruud GA, Frich JC, Andelic N. Health-related quality of life and unmet healthcare needs in Huntington’s disease. Health Qual Life Outcomes. 2017;15(1):6.CrossRefPubMedPubMedCentral
14.
go back to reference van Walsem MR, Howe EI, Iversen K, Frich JC, Andelic N. Unmet needs for healthcare and social support services in patients with Huntington’s disease: a cross-sectional population-based study. Orphanet J Rare Dis. 2015;10:124.CrossRefPubMedPubMedCentral van Walsem MR, Howe EI, Iversen K, Frich JC, Andelic N. Unmet needs for healthcare and social support services in patients with Huntington’s disease: a cross-sectional population-based study. Orphanet J Rare Dis. 2015;10:124.CrossRefPubMedPubMedCentral
15.
go back to reference Murman DL, Chen Q, Colucci PM, Colenda CC, Gelb DJ, Liang J. Comparison of healthcare utilization and direct costs in three degenerative dementias. Am J Geriatr Psychiatry. 2002;10(3):328–36.CrossRefPubMed Murman DL, Chen Q, Colucci PM, Colenda CC, Gelb DJ, Liang J. Comparison of healthcare utilization and direct costs in three degenerative dementias. Am J Geriatr Psychiatry. 2002;10(3):328–36.CrossRefPubMed
17.
go back to reference Fu MY, Guan XD, Wei GX, Xin XX, Shi LW. Medical service utilisation, economic burden and health status of patients with rare diseases in China. J Chin Pharm Sci. 2018;27(5):361–9.CrossRef Fu MY, Guan XD, Wei GX, Xin XX, Shi LW. Medical service utilisation, economic burden and health status of patients with rare diseases in China. J Chin Pharm Sci. 2018;27(5):361–9.CrossRef
18.
go back to reference Dhingra SS, Zack M, Strine T, Pearson WS, Balluz L. Determining prevalence and correlates of psychiatric treatment with Andersen’s behavioral model of health services use. Psychiatr Serv. 2010;61(5):524–8.CrossRefPubMed Dhingra SS, Zack M, Strine T, Pearson WS, Balluz L. Determining prevalence and correlates of psychiatric treatment with Andersen’s behavioral model of health services use. Psychiatr Serv. 2010;61(5):524–8.CrossRefPubMed
19.
go back to reference Ma Z, Zheng XY. Analysis of the health service utilization among patients with rare diseases and the influencing factors in China. Chin J Health Policy. 2018;11(11):56–60. Ma Z, Zheng XY. Analysis of the health service utilization among patients with rare diseases and the influencing factors in China. Chin J Health Policy. 2018;11(11):56–60.
20.
go back to reference Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127–40.CrossRefPubMed Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127–40.CrossRefPubMed
Metadata
Title
Health services utilization of Chinese patients with Huntington’s disease: a cross-sectional study
Authors
Huiyi Ke
Xi Cao
Yanyan Song
Li Cao
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2021
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-021-06826-1

Other articles of this Issue 1/2021

BMC Health Services Research 1/2021 Go to the issue